Health Condition 1: null- Diabetes Health Condition 2: E088- Diabetes mellitus due to underlying condition with unspecified complications
Conditions
Interventions
None listed
Sponsors
Sanofi India Limited
Eligibility
Inclusion criteria
Inclusion criteria: 1.All male and female adult people (who have attained his/her majority) diagnosed with type 1 or type 2 diabetes, visiting the physician during the recruitment period of the crossâ??sectional study, up to the number of patients allocated to the physician. 2. Written informed consent.
Exclusion criteria
Exclusion criteria: 1. Concomitant participation to a clinical trial. 2. Previous participation in this study. 3. Current temporary insulin therapy (gestational diabetes, surgery, pancreas cancer).
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| To assess the management of care of people with type 2 diabetes in current medical practice Timepoint: 1 year | — |
Secondary
| Measure | Time frame |
|---|---|
| 1. To assess the management of care of people with type 1 diabetes in current medical practice.Timepoint: This is cross sectional study means the data would be collected in the one specific point of time from the patient during the course of the study.;2. To assess the predictive factors for reaching target HbA1c in people with type 1 and type 2 diabetes.Timepoint: Not applicable | — |
Countries
Algeria, Bangladesh, Cameroon, Congo, Egypt, India, Iran (Islamic Republic of), Iraq, Jordan, Kenya, Kuwait, Lebanon, Madagascar, Morocco, Nigeria, Pakistan, Russian Federation, Senegal, South Africa, Tunisia, Ukraine, United Arab Emirates
Contacts
Public ContactMs Vaishali Kanade
Sanofi India Limited
Outcome results
None listed